Yaser Alkhatib, M.D.
Department of General Oncology, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2009 | University of Jordan, Amman, JOR, MD, Medicine |
Postgraduate Training
| 2014-2017 | Clinical Fellowship, Hematology and Medical Oncology, Henry Ford Hospital/Wayne State University, Detroit, MI |
| 2011-2014 | Clinical Residency, Internal Medicine, Henry Ford Hospital/Wayne State University, Detroit, MI |
| 2009-2010 | Clinical Internship, Al-Esra Hospital, Amman |
Board Certifications
| 2017 | American Board of Oncology |
| 2017 | American Board of Hematology |
| 2014 | American Board of Internal Medicine |
Experience & Service
Academic Appointments
Assistant Professor, Division of Internal Medicine, McGovern Medical School at UTHealth, Houston, TX, 2022 - Present
Staff Physician, Department of Hematology and Medical Oncology, Henry Ford Hospital Health System, Detroit, MI, 2017 - 2021
Administrative Appointments/Responsibilities
Core Faculty, Department of Hematology/Oncology Fellowship Program, Henry Ford Hospital/Wayne State University, Detroit, MI, 2019 - 2021
Fellowship Research Supervisor, Henry Ford Hospital/Wayne State University, Detroit, MI, 2019 - 2021
Other Appointments/Responsibilities
Chief Fellow, Henry Ford Hospital/Wayne State University, Detroit, MI, 2016 - 2017
Honors & Awards
| 2017 | Fellow of the Year Award, Henry Ford Hospital |
| 2016 | Dudak Award for Research, Henry Ford Hospital |
Selected Publications
Peer-Reviewed Articles
- Arora K, Rodgers S, Alkhatib Y, Onwubiko IN, Padmanabhan A, Otrock ZK. P-selectin expression assay in a repeatedly serotonin-release assay-negative patient with heparin-induced thrombocytopenia. Blood Coagul Fibrinolysis 32(7):522-525, 2021. PMID: 34261860.
- Abdel Rahman ZH, Miller KC, Jabbour H, Alkhatib Y, Donthireddy V. Outcomes of patients with thrombocytopenia evaluated at hematology subspecialty clinics. Hematol Oncol Stem Cell Ther. e-Pub 2021. PMID: 33607100.
- Alkhatib Y, Abdel Rahman Z, Kuriakose P. Clinical impact of metformin in diabetic diffuse large B-cell lymphoma patients: a case-control study. Leuk Lymphoma 58(5):1130-1134, 2017. e-Pub 2016. PMID: 27701994.
- Alkhatib Y, Guo Y. Lymphadenopathy in a patient with chronic myeloid leukaemia. Br J Haematol 174(2):174, 2016. e-Pub 2016. PMID: 27174048.
- Alkhatib Y, Albashaireh D, Al-Aqtash T, Awdish R. The role of tyrosine kinase inhibitor "Lapatinib" in pulmonary hypertension. Pulm Pharmacol Ther 37:81-4, 2016. e-Pub 2016. PMID: 26965087.
- Gulati R, Alkhatib Y, Donthireddy V, Felicella MM, Menon MP, Inamdar KV. Isolated Ocular Manifestation of Relapsed Chronic Myelogenous Leukemia Presenting as Myeloid Blast Crisis in a Patient on Imatinib Therapy: A Case Report and Review of the Literature. Case Rep Pathol 2015:380451, 2015. e-Pub 2015. PMID: 26819793.
- Hassan S, Yee V, Amer S, Alkhatib Y. Spontaneous intestinal haematoma associated with neurofibromatosis type-1. BMJ Case Rep 2013, 2013. e-Pub 2013. PMID: 23975920.
- Sheqwara J, Alkhatib Y. Sideroblastic anemia secondary to zinc toxicity. Blood 122(3):311, 2013. PMID: 24032127.
- Sheqwara J, Alkhatib Y, Dabak V, Kuriakose P. Idiopathic erythrocytosis in dialysis patients: a case report and literature review. Am J Nephrol 37(4):333-8, 2013. e-Pub 2013. PMID: 23548871.
Abstracts
- Rous FA, Singh SRK, Li P, Elgamal M, Abunafeesa H, Chacko R, Vuyyala S, Alkhatib Y and Kuriakose P. Satisfaction of Hem/Onc Patients with Video Visits During the COVID-19 Pandemic at a Tertiary Care Center in Michigan. Journal of Clinical Oncology 39(28 Suppl):185-185, 2021.
- Gelovani DJ, Franz B, Bizri L and Alkhatib Y. Fatal Pulmonary Cement Embolism After Percutaneous Vertebroplasty in a Patient with Multiple Myeloma. Journal of General Internal Medicine 36(SUPPL 1):S225-S226, 2021.
- Hammoudeh R, Alkhatib Y, Sabha Q. Major Bleeding Outcomes for Admitted Immune Thrombocytopenia Patients with Platelets Less Than 10K: A Single- Center Experience. Blood 136(Supplement 1):21 - 22, 2020.
- Balanchivadze N, Slota AA, Mangano A, Kudirka A and Alkhatib. Physician Perceptions about Goals of Care of Hospitalized Patients with Malignancies. Journal of Clinical Oncology 35(15 Suppl):e19234 - e19234, 2020.
- Sharma S, Alkhatib Y and Paul T. Hyperammonemic Encephalopathy: A Tale of an Innocent Liver. Henry Ford Health System Medical Education Research Forum Case Reports 58, 2019.
- Khaddour L, Al Saheli Z, Alkhatib Y, Abouljoud M, Kuriakose P. One-Week Prophylaxis with Enoxaparin after Hospital Discharge Is Effective in Preventing Venous Thromboembolism in Living Liver Donors- Single Institution Retrospective Analysis. Blood 134(Supplement 1):2442, 2019.
- Singh SRK, Malapati SJ, Kumar R, Thanikachalam K and Alkhatib Y. Predictors of Transfer to Different Facility at Discharge in Patients Admitted with Metastatic Solid Malignancy: Five-year National Inpatient Sample (NIS) Database Analysis. Journal of Clinical Oncology 37(31 suppl):38 - 38, 2019.
- Alkhatib Y, Dadla A, Malik D, Abdel-Rahman Z, Kuriakose P, Dabak VS and Donthireddy V. Plasmapheresis, and Myeloma Cast Nephropathy: A Meta-Analysis and Review of Evidence. Blood 130(Supplement 1):5415, 2017.
- Abdel-Rahman Z, Alsafadi K, Jabbour H, Mendiratta V, Alkhatib Y and Donthireddy V. Hematology Referrals for Mild Thrombocytopenia in a Tertiary Center in Detroit: A Step Towards a Standardized Approach for Referrals and Testing. Blood 130(Supplement 1):4655, 2017.
- Abdel-Rahman Z, Alkhatib Y and Dabak V. A Mysterious Cause of Chest Pain. Journal of General Internal Medicine 32(2):S412, 2017.
- Abdel-Rahman Z, Alkhatib Y and Dabak V. De Novo Splenic CD5+ DLBCL. Journal of General Internal Medicine 31(233), 2016.
- Alkhatib Y, Nabi S and Peres E. Racial Impact on Cytogenetic Variations and Outcome in Chronic Lymphocytic Leukemia Patients. Blood 128(22):3209, 2016.